PMGC Holdings

What PMGC Holdings does

PMGC Holdings Inc. (NASDAQ: ELAB) is a publicly traded diversified holding company headquartered in Newport Beach, California, that operates a U.S.-based precision manufacturing and specialty assets roll-up platform under a stated "permanent capital" philosophy. The company is the successor to Elevai Labs Inc., which completed a $6M IPO in November 2023 in the exosome skincare/aesthetics space before divesting Elevai Skincare to Carmell in January 2025 and pivoting to acquire cash-flowing U.S. manufacturing businesses. Since July 2025, PMGC has completed five acquisitions — Pacific Sun Packaging ($1.148M), AGA Precision Systems ($650K), Indarg Engineering (bolt-on via AGA), SVM Machining / Silicon Valley Manufacturing ($2.25M), and A&B Aerospace ($4.5M) — building a multi-site precision CNC machining platform with AS9100/AS9100D-certified and ITAR-registered subsidiaries serving Tier 1 aerospace and defense customers including Boeing, Honeywell, and Moog under long-term supply agreements.

Operating subsidiaries cluster around three pillars: (1) precision CNC manufacturing (multi-axis, Swiss, 5-axis machining with tolerances as tight as ±0.0001 inches across titanium, Inconel, stainless steel, and aluminum alloys) supporting aerospace, defense, space, medical, biotech, and semiconductor capital equipment customers; (2) specialty IT hardware protective packaging via Pacific Sun Packaging, serving 300+ commercial customers across North American semiconductor, data center, and IT supply chains; and (3) biopharmaceutical and defense technology assets held through NorthStrive Biosciences (EL-22 and EL-32 myostatin-engineered probiotics with FDA-supported Phase 2 IND pathway in combination with GLP-1 receptor agonists) and NorthStrive Defense Tech (license options on two issued U.S. patents covering GPS-denied drone navigation and multi-domain payload transport). An additional investment arm, PMGC Capital LLC, holds a minority stake in Nuclea Energy Inc. (Micro Modular Reactor developer) and General Enterprise Ventures.

Revenue is generated through negotiated quote-based pricing under long-term supply agreements for precision components, unit pricing for IT packaging, and royalty-bearing exclusive licenses for biopharmaceutical assets (e.g., Modulant Biosciences for animal health; MOA Life Plus for human health). The GTM model combines direct enterprise field sales to Tier 1 primes, channel partnerships with co-advisors NorthStrive Companies and GB Capital for M&A sourcing and integration, event-driven international expansion (e.g., ITAD Europe 2026), and an OEM/licensing-out model for biopharma IP. Capital deployment is supported by a fully utilized $20M Streeterville equity purchase facility and a $40M equity purchase facility closed in April 2026 with Univest Securities as placement agent. The company is early-stage in consolidated scale: Q1 2026 reported revenue was approximately $682,000 against full FY2025 revenue of approximately $590,000, though acquired subsidiaries contribute a substantially larger pro forma revenue base that will consolidate over FY2026.

Name

PMGC Holdings

Legal name

PMGC Holdings Inc.

Website

https://pmgcholdings.com

Company type

Public

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

PMGC Holdings Inc. (NASDAQ: ELAB) is a publicly traded diversified holding company that acquires and operates U.S.-based precision CNC manufacturing (aerospace/defense), specialty IT packaging, biopharmaceutical, and defense technology subsidiaries through a permanent-capital roll-up strategy.

Ownership category

akta.pro rank

Product category

Precision Manufacturing Services

NAICS

Industrial Machinery Manufacturing (33324), Pharmaceutical Preparation Manufacturing (325412), Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing (334511)

SIC

Search, Detection, Navagation, Guidance, Aeronautical Sys (3812), Special Industry Machinery, Nec (3559), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYIMAHAHAH

Industrial Controllers & Control Systems (PLCs, PACs, CNC Controllers)

Industrials, Manufacturing & Construction/Industrial Machinery & Heavy Equipment/Industrial Automation & Robotics Equipment

SECONDARYHLAGAGAL

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

SECONDARYFSANAHAF

Corporate Strategic Partnership & Ecosystem Investment Arms

Financial & Insurance/Private Equity & Venture Capital/Corporate Venture Capital (CVC)

Keywords

• Precision CNC machining
• Aerospace defense manufacturing
• Specialty IT packaging
• Biopharmaceutical development
• Diversified holding company

Headquarters

HQ city

Davis

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Precision CNC Manufacturing Services: Recurring and project-based revenue from CNC precision machining services (5-axis, Swiss, multi-tasking turning) sold to aerospace, defense, medical, semiconductor, and industrial customers under long-term supply agreements (LTAs). Includes production runs for Tier 1 OEMs (Boeing, Honeywell, Moog).
2. Specialty IT Hardware Packaging: Sales of custom-engineered protective packaging solutions (Pacific Sun Packaging) for semiconductors, CPUs, GPUs, memory, SSDs, fiber-optic transceivers, and other IT/data center hardware to OEMs, distributors, and ITAD providers.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Core offering

PMGC Holdings Inc. is a diversified holding company that acquires and operates U.S.-based cash-flowing manufacturing and technology businesses under a long-term 'permanent capital' philosophy. Its operating subsidiaries produce precision CNC-machined components (5-axis, Swiss, multi-tasking) for aerospace and defense customers, custom-engineered protective packaging for IT/semiconductor hardware, biopharmaceutical assets (EL-22 and EL-32 myostatin-engineered probiotics) developed under licensing partnerships, and licensed defense technologies (GPS-denied drone navigation and multi-domain drone payload systems).

Product overview

PMGC Holdings Inc. (NASDAQ: ELAB) operates as a diversified holding company rather than a single unified software product. Its offering is a portfolio of U.S.-based operating subsidiaries grouped around a precision manufacturing platform — AGA Precision Systems LLC, SVM Machining, Inc. (Silicon Valley Manufacturing), and A&B Aerospace, Inc. — alongside non-manufacturing verticals including Pacific Sun Packaging (custom IT packaging), NorthStrive Biosciences (biopharmaceutical / muscle-preservation assets EL-22 and EL-32, augmented by an AI Development Program with Yuva Biosciences on the MitoNova platform), NorthStrive Defense Tech (defense technology licensing), and PMGC Capital LLC (investment arm). The subsidiaries function as independent brands under the holding-company umbrella rather than modules of a single product.

Differentiator

Problem solved

Functional benefit

Brands

• AGA Precision: Precision CNC machining subsidiary serving aerospace, defense, space, and industrial sectors.
• NorthStrive Bio
• Pacific Sun Packaging
• NorthStrive Defense Tech
• A&B Aerospace

Products and services

• AGA Precision Systems LLC Wholly-owned subsidiary providing AS9100-certified and ITAR-registered precision CNC machining services for aerospace, defense, space, and industrial customers, including multi-axis milling, turning, mold manufacturing, and complex metals machining (titanium, Inconel, stainless steel, aluminum alloys).
• SVM Machining, Inc. (Silicon Valley Manufacturing) Wholly-owned subsidiary providing ISO 9001:2015-certified precision CNC machining and manufacturing services for medical, aerospace, biotech & pharmaceutical, semiconductor, and transportation markets; founded 1997 by Mark Serpa.
• A&B Aerospace, Inc. Wholly-owned subsidiary providing precision machining and aerospace manufacturing with 20+ modern CNC machines with full 5-axis capabilities in Azusa, California; serves Tier 1 customers including Boeing, Honeywell, and Moog.
• Pacific Sun Packaging, Inc. Wholly-owned subsidiary providing custom-engineered protective packaging for CPUs, GPUs, memory modules, SSDs, fiber-optic transceivers, HDDs, and other high-value IT/semiconductor/data center components; serves 300+ commercial customers.
• NorthStrive Biosciences (EL-22 and EL-32 Engineered Probiotics) Wholly-owned biopharmaceutical subsidiary developing EL-22 and EL-32 oral engineered probiotics leveraging myostatin and activin-A pathways to preserve lean muscle mass in patients undergoing GLP-1 receptor agonist weight loss therapy; supports human and animal health applications via licensing partnerships.
• NorthStrive Defense Tech LLC Wholly-owned defense technology subsidiary licensing patented GPS-denied autonomous drone navigation and multi-domain drone payload transport technologies for defense, counter-drone (C-UAS), electronic warfare, and autonomous unmanned aircraft systems applications.

Quantifiable outcome

• Total assets grew 102% from YE2025 to Q1 2026 (to ~$26M); up 193% YoY
• +6 more outcomes

Named customers7 records

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

15 partnerships are on record, tiered high — anticipated defense customer and partner for northstrive defense tech, core licensing partner for human clinical development of el-22/el-32, flagship licensing partner for animal health commercialization of el-22/el-32, core m&a co-advisor, core m&a co-advisor; subsequent co-advisor on a&b aerospace acquisition (may 12, 2026), legacy regional distributor — elevai labs philippines market (now divested), core strategic customer-partner for long-term supply framework, flagship — strategic ai drug discovery partner for muscle preservation / mitochondrial health compounds, legacy regional distributor — kuwait market, legacy regional distributor — vietnam market, legacy regional distributor — canada market, legacy global aesthetics partner, core legal counsel, core auditor and core transfer agent.

• U.S. Department of Defense / U.S. Navy (anticipated future engagement)high — anticipated defense customer and partner for northstrive defense techStrategic or Co-development Partner · 2 April 2026NorthStrive Defense Tech LLC was formed April 2, 2026 as wholly-owned subsidiary targeting defense technology, drone, and autonomous systems. Sponsored research agreements (12-month) intended to validate trajectory control and hydrodynamic stability for multi-domain drone payload technology; research intended to inform potential future engagement with U.S. DoD and U.S. Navy. Also referencing AUKUS Pillar Two and U.S. Navy unmanned surface vessel programs.
• MOA Life Plus Co., Ltd. (KOSDAQ: 142760)core licensing partner for human clinical development of el-22/el-32OEM/ Whitelabel/ Licensing Partner · 27 March 2026Existing License Agreement with NorthStrive Biosciences for EL-32 and EL-22 human clinical development programs; third amendment announced March 27, 2026 updates timing and key development milestones aligned with R&D and regulatory expectations. Korean biotechnology company focused on therapeutic and wellness technologies.
• Modulant Biosciences LLCflagship licensing partner for animal health commercialization of el-22/el-32OEM/ Whitelabel/ Licensing Partner · 11 February 2026Definitive exclusive license agreement with NorthStrive Biosciences Inc. for worldwide (excluding Republic of Korea) development, manufacture, and commercialization of EL-22 and EL-32 myostatin-engineered probiotics for non-human animal health applications (including feed additives). Converts binding term sheet dated May 12, 2025 into definitive deal; royalty-bearing, sublicensable, shared IP ownership of improvements. Modulant led by Dr. Tom Campi.
• GB Capital Ltd.core m&a co-advisorImplementation/ SI/ Consulting Partner · 2 February 2026Co-advisor to PMGC Holdings in the acquisition of SVM Machining, Inc. (closed February 2, 2026). Provided post-closing transition services including financial back-office support and implementation of the C.O.R.E. Financial Framework to standardize accounting and reporting for PMGC's manufacturing platform.
• NorthStrive Companies Inc.core m&a co-advisor; subsequent co-advisor on a&b aerospace acquisition (may 12, 2026)Implementation/ SI/ Consulting Partner · 2 February 2026Co-advisor to PMGC Holdings in the acquisition of SVM Machining, Inc. (closed February 2, 2026). Provided financial advisory, due diligence, transaction execution, and post-close transition services using proprietary G.A.G.E.™ framework. Subsequently co-advised on A&B Aerospace acquisition (closed May 12, 2026).
• Dmark Multisales Corporationlegacy regional distributor — elevai labs philippines market (now divested)Channel Partner/ Reseller/ Distributor · 13 May 2025Exclusive Philippines distributor for ELEVAI Labs exosome skincare products (signed August 1, 2023). Historical international distribution partnership. Elevai Skincare subsequently divested to Carmell in January 2025.
• Turbo-Jet Products Co., Inc.core strategic customer-partner for long-term supply frameworkStrategic or Co-development Partner · 12 May 2025Five-year Long-Term Agreements signed by both AGA Precision Systems (March 31, 2026) and SVM Machining (April 21, 2026) for supply of mission-critical aerospace/defense components supporting commercial and defense programs. AS9100 Rev. D / ISO 9001:2015 certified designer/manufacturer of custom electromagnetic, electromechanical, mechanical, fluid, and pneumatic controls; serving aerospace, military, transportation, and medical industries since 1948.
• Yuva Biosciences, Inc.flagship — strategic ai drug discovery partner for muscle preservation / mitochondrial health compoundsStrategic or Co-development Partner · 10 April 2025AI Development Program partnership signed April 10, 2025 with NorthStrive Biosciences. Advanced to Phase III in December 2025 with deployment of improved sixth-generation classifier models; Phase III results now expected Q2 2026. Yuva operates MitoNova™ AI platform for mitochondrial sciences discovery. Multiple products incorporating Yuva-discovered compounds already on market (e.g., Revive+ by BosleyMD).
• Central Circle Companylegacy regional distributor — kuwait marketChannel Partner/ Reseller/ Distributor · 8 June 2023International distributor agreement for ELEVAI Labs in Kuwait (signed June 8, 2023). Historical partnership predating Elevai Skincare divestiture.
• Viet Can Trading and Service Co., Ltd.legacy regional distributor — vietnam marketChannel Partner/ Reseller/ Distributor · 18 May 2023Distribution partnership with ELEVAI Labs for Vietnam market (signed May 18, 2023). Historical partnership predating Elevai Skincare divestiture.
• Evolve Medical Inc.legacy regional distributor — canada marketChannel Partner/ Reseller/ Distributor · 21 February 2023Canadian distribution agreement with ELEVAI Labs (signed February 21, 2023). Historical partnership predating Elevai Skincare divestiture.
• DermapenWorldlegacy global aesthetics partnerStrategic or Co-development Partner · 21 January 2022Global distribution partnership with premier aesthetic device company DermapenWorld announced January 21, 2022 for ELEVAI Labs exosome skincare products. Historical partnership predating Elevai Skincare divestiture.
• Sichenzia Ross Ference Carmel LLPcore legal counselImplementation/ SI/ Consulting PartnerLegal counsel listed on PMGC corporate directory; located at 1185 Avenue of the Americas, 31st floor, New York, NY 10036.
• HTL CPAS & Business Advisorscore auditorImplementation/ SI/ Consulting PartnerAuditor listed on PMGC corporate directory.
• VStock Transfer, LLCcore transfer agentImplementation/ SI/ Consulting PartnerTransfer agent for PMGC common stock; located at 18 Lafayette Place, Woodmere, New York 11598. Handles shareholder services including the January 2026 and March 2026 reverse stock splits.

Scale indicators19 records

Recent moves8 records

Expansion highlights7 records

Broad incumbents

• TransDigm Group Incorporated: Public aerospace components holding company that has compounded value through decades of disciplined, M&A-driven expansion of proprietary, sole-source aerospace parts. Highly comparable as the canonical aerospace-defence roll-up model that PMGC aspires to emulate, though at vastly greater scale.
• HEICO Corporation: Public aerospace and electronics manufacturer that has grown primarily through acquisitions of niche PMA parts and specialty aerospace manufacturers. Comparable as an established, profitable aerospace-defence precision manufacturing roll-up, though at much larger scale.
• Curtiss-Wright Corporation: Public manufacturer of highly engineered, mission-critical products for defense, commercial and industrial markets, with significant precision machining and metal-treatment capabilities. Comparable as a publicly listed precision aerospace/defence/industrial manufacturer operating at higher scale across similar end markets.
• Shield AI: Private defense-technology company building autonomous UAVs (Hivemind) with AI-pilot capabilities for GPS-denied and contested environments. Comparable to PMGC's NorthStrive Defense Tech and its licensed GPS-denied visual-inertial cooperative navigation patent (U.S. Patent 12,277,716 B2).
• Barnes Group Inc. Public industrial and aerospace manufacturer producing precision-engineered components, including complex metal parts for aerospace and defense OEMs. Comparable as a publicly listed precision manufacturer serving overlapping Tier 1 aerospace customers.
• Regeneron Pharmaceuticals, Inc. Large biopharma with a long-standing clinical program in myostatin inhibition (trevogrumab / REGN1033) and muscle biology. Comparable as a broad incumbent validating the myostatin pathway that PMGC's EL-22/EL-32 programs target, with much deeper resources.
• Elbit Systems Ltd. Public Israeli defense electronics company with significant unmanned aerial systems, autonomous, and precision-munitions franchises. Comparable to NorthStrive Defense Tech's drone/autonomous-systems positioning, while also serving as a broader aerospace/defense precision-technology incumbent.

Direct peers

• Scholar Rock Holding Corporation: Clinical-stage biopharma developing myostatin-targeted therapeutics (apitegromab) for muscle preservation, including in patients on GLP-1 receptor agonists. Directly comparable to PMGC's NorthStrive Biosciences EL-22/EL-32 myostatin-engineered probiotic program, as both target the same myostatin biology and the GLP-1 muscle-loss clinical context.

Emerging players

• Anduril Industries: Private defense-technology company developing autonomous systems, drones, and counter-UAS capabilities, with a growing footprint in maritime unmanned platforms. Comparable to PMGC's NorthStrive Defense Tech multi-domain drone payload and autonomous-systems strategy.
• BioAge Labs, Inc. Clinical-stage biopharma developing therapeutics for metabolic diseases, including muscle preservation in obesity/GLP-1 contexts. Comparable as an emerging muscle-preservation developer focused on the same GLP-1-adjacent white space that PMGC's EL-22 targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/elevaiofficial

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries9 records

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PMGC Holdings